Form 4: Select Medical Holdings Corp. Merger Transaction Disclosed
Statement of Changes in Beneficial Ownership
Robert G. Breighner Jr. reports changes in beneficial ownership of Select Medical Holdings Corp. common stock related to a merger transaction.
Summary
- Robert G. Breighner Jr., Senior Vice President at Select Medical Holdings Corporation, has filed a Form 4 detailing transactions related to the company's merger.
- The filing indicates a disposition of 16,334 restricted shares ('Rollover Shares') and 18,362 shares of common stock.
- These transactions occurred on June 30, 2026, in connection with the Agreement and Plan of Merger.
- Breighner contributed 16,334 Rollover Shares to Parent in exchange for equivalent shares of Parent's common stock and restricted shares.
- Subsequently, these Parent Common Shares were exchanged for interests in Stallion Group Parent, LP.
- Additionally, 18,362 shares of Select Medical Holdings Corp. common stock were converted into the right to receive $16.50 per share in cash as Merger Consideration.
- This Merger Consideration was subject to applicable tax withholdings.
- The filing also notes unvested Company Restricted Shares that vested in full prior to the merger's effective time and were converted into Merger Consideration.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports on a completed merger transaction and insider share disposition, which is a procedural disclosure rather than an indicator of new performance or strategic shifts.
Positives
- The merger transaction provides a cash payout of $16.50 per share for common stock, representing a clear value realization for shareholders involved in the transaction.
- The contribution of Rollover Shares in exchange for Parent Common Shares and subsequent exchange for interests in Stallion Group Parent, LP, indicates a structured rollover mechanism for certain equity holders.
Negatives
- The disposition of a significant number of shares (16,334 restricted shares and 18,362 common shares) by a Senior Vice President could be perceived negatively by the market, although it is directly tied to a merger.
- The Merger Consideration is subject to applicable tax withholdings, reducing the net amount received by the reporting person.
Risks
- The filing does not explicitly detail risks associated with the merger itself, but the conversion of shares into cash implies the cessation of direct equity ownership in Select Medical Holdings Corp. for the reporting person.
- Potential tax implications for the reporting person related to the merger consideration and share exchanges are not detailed but are a factor.
Future Outlook
The filing primarily reports on past transactions related to a completed merger. No specific forward-looking statements or guidance from the company are included in this Form 4.
Management Comments
- The filing is a statement of changes in beneficial ownership and does not contain direct quotes or paraphrased statements from management regarding strategy or outlook.
- Explanations within the filing detail the mechanics of the merger, such as the contribution of Rollover Shares and the conversion of common stock into Merger Consideration.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, particularly relevant during significant corporate events like mergers. This filing confirms the execution of a previously announced merger agreement for Select Medical Holdings Corp., providing clarity on how a key executive's holdings were affected.
Stakeholder Impact
- Shareholders who held common stock in Select Medical Holdings Corp. prior to the merger would have received $16.50 per share in cash, representing a liquidity event.
- Employees holding restricted stock (Company Restricted Shares) would have seen their unvested shares vest and convert into cash consideration.
- The reporting person, Robert G. Breighner Jr., as Senior Vice President, has had his beneficial ownership change significantly due to the merger, transitioning from direct equity in the company to cash and interests in the acquiring entity.
Next Steps
- The merger transaction appears to have been completed as of June 30, 2026, based on the transaction dates reported.
- Further filings may be required to report any ongoing beneficial ownership changes or post-merger activities.
Key Dates
| Date | Description |
|---|---|
| 03/02/2026 | Date of the Agreement and Plan of Merger. |
| 03/03/2026 | Date of Form 8-K filing with the Securities and Exchange Commission detailing the Merger Agreement. |
| 06/30/2026 | Earliest transaction date reported in the Form 4, representing the effective time of certain merger-related transactions. |
| 07/01/2026 | Date of the signature on the Form 4 filing. |
Keywords
Form 4, SEC Filing, Select Medical Holdings Corp., SEM, Merger, Beneficial Ownership, Robert G. Breighner Jr., Insider Trading, Stock Disposition, Restricted Stock, Common Stock, Merger Consideration
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.